ImmunityBio (IBRX) Revenue (2014 - 2026)
ImmunityBio's Revenue was $51.24 million in Q2 2026, up 93.9% from $26.43 million a year earlier and up 15.9% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Revenue (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, ImmunityBio's Revenue was $165.79 million through Jun 30, 2026, up 192.9% year-over-year; for FY2025, it came in at $113.29 million, up 668.3% from FY2024.
- Revenue shows a five-year compound annual growth rate of 184.8% (FY2020 to FY2025).
- In earlier years, Revenue was $14.75 million in FY2024, $622,000 in FY2023 (+159.2%), $240,000 in FY2022 (-74.3%) and $934,000 in FY2021 (+54.4%).
- The Q2 2026 figure marks the highest quarterly Revenue in data going back to Q1 2014.
- Compared with a year earlier, Revenue has increased for four straight quarters, with growth averaging 273.4% over the last four quarters.
- The best year-over-year quarter for Revenue over five years was Q3 2025 (growth of 425.1%); the worst was Q1 2022 (a decline of 89.9%).
- Per Business Quant data, IBRX's Revenue in the three quarters before Q2 2026 was $44.21 million (Q1 2026), $38.29 million (Q4 2025) and $32.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | 51.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.24 Mn |
| Mar 31, 2026 | 44.21 Mn |
| Dec 31, 2025 | 38.29 Mn |
| Sep 30, 2025 | 32.06 Mn |
| Jun 30, 2025 | 26.43 Mn |
| Mar 31, 2025 | 16.52 Mn |
| Dec 31, 2024 | 7.55 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 139,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 360,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Sep 30, 2022 | 118,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 390,000.00 |
| Sep 30, 2021 | 66,000.00 |
API Access
ImmunityBio Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();